100.00% -0.45

Dopo l'orario di chiusura: .26 0.26 +

Protagenic Therapeutics Inc (PTIX)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Frazionamento azionario

Protagenic Therapeutics Inc Borsa (PTIX) Ultime notizie

Protagenic Therapeutics Inc (PTIX)

Protagenic Therapeutics Inc Borsa (PTIX) Ultime notizie

Enterprise value to EBIT forward of Protagenic Therapeutics, Inc. – OTC:PTIX - TradingView

Price to earnings forward of Protagenic Therapeutics, Inc. – OTC:PTIX - TradingView

Enterprise value to revenue forward of Protagenic Therapeutics, Inc. – MUN:MBP0 - TradingView

Price to book forward of Protagenic Therapeutics, Inc. – MUN:MBP0 - TradingView

Price to sales forward of Protagenic Therapeutics, Inc. – MUN:MBP0 - TradingView

Protagenic Therapeutics' Lead Candidate PT00114 Attenuated Chronic Stress Responses in a Well-Established Rodent Model - ACCESS Newswire

Protagenic Therapeutics announces publication of PT00114 preclinical data - TipRanks

Protagenic Therapeutics Delays Annual 10-K Filing - TipRanks

Protagenic Therapeutics (NASDAQ: PTIX) delays 10-K; expects filing within 15 days - Stock Titan

Protagenic Therapeutics (PTIX) Unveils Promising Data for PT0011 - GuruFocus

Protagenic Therapeutics, Inc. Actuals & Estimates (OTC:PTIX) - TradingView

Protagenic Therapeutics Inc (PTIX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Protagenic Therapeutics Inc (PTIX) Valuation: PE, PB & Fair Value Analysis - TradingKey

Protagenic Therapeutics Inc (PTIX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Protagenic Therapeutics Inc (PTIX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Protagenic Therapeutics Inc (PTIX) Institutional Confidence - TradingKey

Protagenic Therapeutics Inc (PTIX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Protagenic Therapeutics Inc (PTIX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Protagenic Therapeutics Inc (PTIX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Protagenic Therapeutics Inc (PTIXW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Protagenic Therapeutics Inc (PTIXW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Protagenic Therapeutics Inc - TradingKey

Protagenic Therapeutics Inc (PTIXW) Valuation: PE, PB & Fair Value Analysis - TradingKey

Protagenic Therapeutics Inc (PTIXW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Protagenic Therapeutics Inc (PTIXW) Institutional Confidence - TradingKey

Protagenic Therapeutics Inc (PTIXW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Protagenic Therapeutics Inc (PTIXW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Protagenic Therapeutics Soars: Market Analysis Unfolded - timothysykes.com

PTIXW SEC FilingsProtagenic 10-K, 10-Q, 8-K Forms - Stock Titan

Protagenic Therapeutics (PTIX) Enhances Strategy for PT00114 Dev - GuruFocus

Protagenic Therapeutics Engages Floyd Regulatory Strategic Consulting as Regulatory Affairs Advisor - PharmiWeb.com

Protagenic announces two engagements to support advancement of PT00114 - TipRanks

Protagenic Therapeutics Engages Floyd Regulatory Strategic Consulting as Regulatory Affairs Advisor and Danforth Health as Strategic Operations Partner - ACCESS Newswire

Drug candidate PT00114 taps CNS regulatory veteran for 2026 Phase 2 - Stock Titan

TradingKey - TradingKey

Protagenic Theraputcs Wts (PTIXW) Stock Price and News - The Globe and Mail

Why Is Protagenic Therapeutics, Inc. (PTIX) Stock Up Today? - Meyka

Protagenic Therapeutics Appoints Industry Veteran Bill Nichols Jr. as President to Accelerate Advancement of First-in-Class TCAP Pathway Therapy PT00114 - Caledonian Record

Protagenic names Bill Nichols president, CFO to step down By Investing.com - Investing.com Nigeria

Protagenic Therapeutics Names Bill Nichols Jr. President to Advance Neuropeptide Pipeline Strategy - citybiz

Protagenic names Bill Nichols president, CFO to step down - Investing.com

Protagenic adds ex-bluebird executive as PT00114 moves toward Phase 2 - Stock Titan

PTIX SEC FilingsProtagenic Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Guidance Update: What is the long term forecast for Protagenic Therapeutics Inc stock2026 Volume Leaders & Trade Opportunity Analysis - baoquankhu1.vn

Sentiment Review: Is Protagenic Therapeutics Inc Equity Warrant showing insider buyingWeekly Gains Summary & Weekly Return Optimization Plans - baoquankhu1.vn

Rate Hike: Is Protagenic Therapeutics Inc being accumulated by smart money2026 Winners & Losers & Safe Entry Zone Tips - baoquankhu1.vn

PTIX | PROTAGENIC THERAPEUTICS Insider Trading - Quiver Quantitative

Analyst Upgrade: How much upside does Protagenic Therapeutics Inc have2026 Technical Overview & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn

Investor Mood: What is the long term forecast for Protagenic Therapeutics Inc stockDip Buying & Detailed Earnings Play Alerts - baoquankhu1.vn

PTIX|Protagenic Therapeutics Inc|Price:0.740| - TradingKey

Fed Meeting: Will Protagenic Therapeutics Inc Equity Warrant outperform during market rallies2026 Rallies & Low Drawdown Trading Techniques - baoquankhu1.vn

Market Pulse: Does Protagenic Therapeutics Inc have a sustainable dividendMarket Sentiment Review & Fast Exit and Entry Trade Guides - baoquankhu1.vn

Protagenic Therapeutics Announces Termination of Chief Financial Officer - The Globe and Mail

Trend Review: Whats the beta of Protagenic Therapeutics Inc stock2026 Fundamental Recap & Low Risk Entry Point Guides - baoquankhu1.vn

Protagenic Therapeutics CFO Alexander Arrow to Exit, Termination Effective April 30, 2026 - TradingView — Track All Markets

Simile a PTIX